Status:
COMPLETED
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301
Lead Sponsor:
Novartis
Conditions:
Renal Transplant
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Aim of study is to collect long term safety and tolerability data on enteric-coated mycophenolate sodium with regard to adverse events, serious adverse events, and patient and graft survival. After su...
Eligibility Criteria
Inclusion
- First cadaveric, living unrelated or human antigen mismatched living related donor kidney transplant recipients who completed study CERL080A301
Exclusion
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
December 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2003
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT00149929
Start Date
December 1 1999
End Date
April 1 2003
Last Update
February 2 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.